Frequently Asked Questions
The market is segmented based on , By Product (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) and Implantable Loop Recorder), End User (Hospitals, Specialty Cardiac Centres, Ambulatory Surgical Centres and Others) – Industry Trends and Forecast to 2031.
.
The Global Implantable Cardiac Rhythm Management Market size was valued at USD 18.62 USD Billion in 2023.
The Global Implantable Cardiac Rhythm Management Market is projected to grow at a CAGR of 4.62% during the forecast period of 2024 to 2031.
The major players operating in the market include Medtronic (U.S.), Abbott (U.S.), Stryker (U.S.), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (U.S.), Biotronik (Germany), Integer Holdings Corporation (U.S.), MicroPort Scientific Corporation (China), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), ABIOMED (U.S.), Berlin Heart (Germany), Jarvik Heart, Inc. (U.S.), NIHON KOHDEN CORPORATION (Japan), Defibtech LLC (U.S.), Medicalsystem Co. Ltd. (China), LivaNova PLC (U.K.), Cardiac Science Corporation (U.S.), 3M (U.S.), Mentice (Sweden).
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
